ofloxacin has been researched along with Atypical Mycobacterial Infection, Disseminated in 42 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case experienced pyothorax due to pulmonary tuberculosis three years before and Mycobacterium avium pleuritis one year before this episode." | 1.35 | [Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection]. ( Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H, 2008) |
| "Clarithromycin (CAM) was started for M." | 1.33 | [A case of Mycobacterium fortuitum meningitis following surgery for meningioma]. ( Eguchi, K; Fujikawa, K; Fukuda, T; Motomura, M; Ooe, N; Suenaga, A, 2006) |
| "Linezolid was more active against M." | 1.32 | In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. ( López, M; Rodriguez Díaz, JC; Royo, G; Ruiz, M, 2003) |
| "We report a case of Mycobacterium abscessus infection complicated with diabetes mellitus." | 1.31 | [Mycobacterium abscessus infection complicated with diabetes mellitus]. ( Harada, H; Iwasaki, Y; Minagawa, T; Nagata, K; Nakagawa, M; Nakanishi, M; Natsuhara, A; Takemura, Y, 2002) |
| " These laboratory results concur with our experience of the efficacy of once-daily dosing with these drugs in the treatment of infections caused by M." | 1.29 | Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum. ( Chan, CY; Cheng, AF; Li, MS; Tsui, SY; Yew, WW, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (14.29) | 18.7374 |
| 1990's | 12 (28.57) | 18.2507 |
| 2000's | 18 (42.86) | 29.6817 |
| 2010's | 5 (11.90) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Flores-Suárez, LF | 1 |
| Fernández-Sánchez, M | 1 |
| Ahumada-Topete, VH | 1 |
| Rodríguez, M | 1 |
| Charli-Joseph, Y | 1 |
| Dabas, G | 1 |
| Sharma, K | 1 |
| Narang, T | 1 |
| Sharma, M | 1 |
| Chatterjee, D | 1 |
| Dogra, S | 1 |
| Chen, HW | 1 |
| Lai, CC | 1 |
| Tan, CK | 1 |
| Lin, JN | 1 |
| Lai, CH | 1 |
| Chen, YH | 1 |
| Huang, CK | 1 |
| Lin, HF | 1 |
| Eng, HL | 1 |
| Lin, HH | 1 |
| Sawahata, M | 1 |
| Hagiwara, E | 2 |
| Ogura, T | 2 |
| Komatsu, S | 2 |
| Sekine, A | 2 |
| Tsuchiya, N | 1 |
| Takahashi, H | 2 |
| Ota, R | 1 |
| Iwasawa, MT | 1 |
| Ohkusu, K | 1 |
| Kambe, N | 1 |
| Matsue, H | 1 |
| Omoruyi, OJ | 1 |
| Ip, WY | 1 |
| Fung, BK | 1 |
| Kobashi, Y | 1 |
| Mouri, K | 1 |
| Obase, Y | 1 |
| Kato, S | 1 |
| Oka, M | 1 |
| Fujita, N | 1 |
| Utani, A | 1 |
| Matsumoto, F | 1 |
| Matsushima, H | 1 |
| Kakuta, M | 1 |
| Hatamochi, A | 1 |
| Shinkai, H | 1 |
| Dauendorffer, JN | 1 |
| Laurain, C | 1 |
| Weber, M | 1 |
| Dailloux, M | 1 |
| Rodriguez Díaz, JC | 1 |
| López, M | 1 |
| Ruiz, M | 1 |
| Royo, G | 1 |
| Hisamori, S | 1 |
| Oida, K | 1 |
| Taguchi, Y | 1 |
| Tanaka, E | 1 |
| Inoue, T | 1 |
| Katoh, K | 1 |
| Sakuramoto, M | 1 |
| Minaguchi, M | 1 |
| Maeda, Y | 1 |
| Maniwa, K | 1 |
| Terada, K | 1 |
| Ishimaru, H | 1 |
| Hata, K | 1 |
| Bormann, G | 1 |
| Marsch, WC | 1 |
| Sarayba, MA | 1 |
| Shamie, N | 1 |
| Reiser, BJ | 1 |
| Sweet, PM | 1 |
| Taban, M | 1 |
| Graff, JM | 1 |
| Kesler-Diaz, A | 1 |
| Osann, KE | 1 |
| McDonnell, PJ | 1 |
| Caballero, AR | 1 |
| Marquart, ME | 1 |
| O'Callaghan, RJ | 1 |
| Thibodeaux, BA | 1 |
| Johnston, KH | 1 |
| Dajcs, JJ | 1 |
| Shitrit, D | 1 |
| Baum, GL | 1 |
| Priess, R | 1 |
| Lavy, A | 1 |
| Shitrit, AB | 1 |
| Raz, M | 1 |
| Shlomi, D | 1 |
| Daniele, B | 1 |
| Kramer, MR | 1 |
| Nakagawa, K | 1 |
| Tsuruta, D | 1 |
| Ishii, M | 1 |
| Fujikawa, K | 1 |
| Suenaga, A | 1 |
| Motomura, M | 1 |
| Fukuda, T | 1 |
| Ooe, N | 1 |
| Eguchi, K | 1 |
| Serra, C | 1 |
| Loi, G | 1 |
| Saddi, B | 1 |
| Pautasso, M | 1 |
| Manzin, A | 1 |
| Sato, T | 1 |
| Baba, T | 1 |
| Shinohara, T | 1 |
| Endo, T | 1 |
| Sogo, Y | 1 |
| Nishihira, R | 1 |
| Matsumoto, Y | 1 |
| Moriuchi, R | 1 |
| Arita, K | 1 |
| Ujiie, H | 1 |
| Kodama, K | 1 |
| Shimizu, T | 1 |
| Shimizu, H | 1 |
| Tsui, SY | 1 |
| Yew, WW | 5 |
| Li, MS | 1 |
| Chan, CY | 1 |
| Cheng, AF | 1 |
| Komachi, H | 1 |
| Uchihara, T | 1 |
| Saito, Y | 1 |
| Takewaki, S | 1 |
| Nagai, R | 1 |
| Furukawa, T | 1 |
| Iijima, S | 1 |
| Saito, J | 1 |
| Otsuka, F | 1 |
| Fridolijn Jongevos, S | 1 |
| Prens, EP | 1 |
| Habets, JM | 1 |
| de Jong, JJ | 1 |
| van Gelder, T | 1 |
| IJzermans, JN | 1 |
| Endtz, HP | 1 |
| Weimar, W | 1 |
| Vacher, S | 1 |
| Pellegrin, JL | 1 |
| Leblanc, F | 1 |
| Fourche, J | 1 |
| Maugein, J | 1 |
| Gillespie, SH | 1 |
| Morrissey, I | 1 |
| Everett, D | 1 |
| Schreiber, J | 1 |
| Burkhardt, U | 1 |
| Rüsch-Gerdes, S | 1 |
| Amthor, M | 1 |
| Richter, E | 1 |
| Zugehör, M | 1 |
| Rosahl, W | 1 |
| Ernst, M | 1 |
| Takemura, Y | 1 |
| Iwasaki, Y | 1 |
| Minagawa, T | 1 |
| Nakanishi, M | 1 |
| Nagata, K | 1 |
| Natsuhara, A | 1 |
| Harada, H | 1 |
| Nakagawa, M | 1 |
| Zwoliński, J | 1 |
| Gałazka, J | 1 |
| Hasegawa, T | 1 |
| Watanabe, R | 1 |
| Hayashi, K | 1 |
| Inufusa, A | 1 |
| Nakagawa, H | 1 |
| Tomioka, H | 2 |
| Sato, K | 2 |
| Saito, H | 2 |
| Kwan, SY | 4 |
| Wong, PC | 1 |
| Lee, J | 1 |
| Fujimoto, W | 1 |
| Kanzaki, H | 1 |
| Fujiwara, H | 1 |
| Arata, J | 1 |
| Ma, WK | 3 |
| Lui, KS | 1 |
| Suen, HC | 1 |
| Heap, BJ | 1 |
| Aung-khin, M | 1 |
| Mok, CK | 2 |
| Khin, MA | 1 |
| Watanabe, T | 1 |
| Tsukamura, M | 1 |
| Kita, N | 1 |
| Shimoide, H | 1 |
| Yoshimoto, K | 1 |
| Wada, T | 1 |
| Mitani, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi[NCT01298336] | Phase 3 | 92 participants (Actual) | Interventional | 2011-03-02 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ofloxacin and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man].
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Levofloxacin; Male; Mycobacterium Inf | 2010 |
[Cutaneous infection by Mycobacterium fortuitum biovariant "third group"--a case report and bacteriological examination of the isolate].
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Microbial; Female; Humans; Mycobacterium Infections, | 1990 |
40 other studies available for ofloxacin and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
After all, still a magnificent impersonator.
Topics: Adult; Biopsy; Clofazimine; Diagnostic Errors; Female; Humans; Leprostatic Agents; Mycobacterium; My | 2021 |
Cutaneous non-tubercular mycobacterial infection in pregnancy and treatment consideration.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Linezolid; Mycobacterium fortuitum; Mycobacterium Infe | 2019 |
Arthritis caused by Mycobacterium terrae in a patient with rheumatoid arthritis.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Rheumatoid; Azithromycin; Drug Therapy, Combination; Ethamb | 2009 |
Urinary Mycobacterium szulgai infection in an immunocompetent patient.
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Immunocompetence; Isoniazid; Levof | 2009 |
Maximum growth temperature test for cutaneous Mycobacterium chelonae predicts the efficacy of thermal therapy.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Hyperthermia, In | 2012 |
Metachronous Mycobacterium terrae complex tenosynovitis of the hand.
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Clarithromycin; Hand; Histiocy | 2012 |
Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microb | 2012 |
Levofloxacin alone efficiently treated a cutaneous mycobacterium fortuitum infection.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Drug Administration Schedule; Female; Follo | 2002 |
In vitro sensitivity of Mycobacterium xenopi to five antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacter | 2002 |
In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Gatifloxacin; Humans; Levofloxac | 2003 |
[A case of pulmonaly bulla infection with Mycobacterium fortuitum].
Topics: Aged; Blister; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; | 2003 |
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].
Topics: Adult; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Female | 2004 |
Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Transplantat | 2005 |
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, | 2006 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionam | 2006 |
Successful treatment of a widespread cutaneous Mycobacterium fortuitum infection with levofloxacin.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Mycobacterium; Mycobacterium fortuitum; | 2006 |
[A case of Mycobacterium fortuitum meningitis following surgery for meningioma].
Topics: Clarithromycin; Female; Humans; Levofloxacin; Meningeal Neoplasms; Meningioma; Meningitis, Bacterial | 2006 |
Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Immunocompetence; Kidney Diseases; Mycobacterium fortu | 2007 |
[Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Drainage; Drug Resistance, | 2008 |
Large subcutaneous abscesses caused by Mycobacterium fortuitum infection.
Topics: Abscess; Adult; Anti-Bacterial Agents; Female; Humans; Minocycline; Mycobacterium fortuitum; Mycobac | 2008 |
Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.
Topics: Amikacin; Colony Count, Microbial; Culture Media; Drug Administration Schedule; Humans; Microbial Se | 1993 |
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, An | 1996 |
Mycobacterium marinum skin infection successfully treated with levofloxacin.
Topics: Adult; Anti-Infective Agents; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; | 1997 |
Successful triple-antibiotic therapy for cutaneous infection due to Mycobacterium chelonae.
Topics: Aged; Doxycycline; Drug Therapy, Combination; Ethambutol; Female; Humans; Mycobacterium chelonae; My | 1999 |
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Foot; Humans; Kidney Transplantation; Male; M | 1999 |
Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Fluoroquinolones; Humans; Macrophages | 1999 |
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistan | 2001 |
[Non-tubercular mycobacterial infection of the lungs due to Mycobacterium smegmatis].
Topics: Cardiopulmonary Resuscitation; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Therapy, Combination | 2001 |
[Mycobacterium abscessus infection complicated with diabetes mellitus].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cilastatin; Cilastatin, Imipen | 2002 |
[Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
Topics: Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1992 |
Postoperative osteomyelitis due to Mycobacterium fortuitum. A case report.
Topics: Adolescent; Antitubercular Agents; Combined Modality Therapy; Drug Therapy, Combination; Fracture Fi | 1992 |
Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
Topics: Animals; Disease Models, Animal; Female; Fleroxacin; Leprosy; Mice; Mice, Inbred BALB C; Microbial S | 1991 |
Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections.
Topics: Adult; Female; Humans; Imipenem; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Ofloxa | 1990 |
Ofloxacin therapy of Mycobacterium fortuitum infection: further experience.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, | 1990 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combinati | 1989 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Myco | 1989 |
Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection.
Topics: Adult; Aged; Amikacin; Cardiac Surgical Procedures; Drug Combinations; Female; Humans; Injections, I | 1989 |
Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection.
Topics: Drug Administration Schedule; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoba | 1989 |
[In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Mice; Mycobacteri | 1987 |
[Lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae. Reports of nine cases of M. fortuitum infection and four cases of M. chelonae infection].
Topics: Adolescent; Aged; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontu | 1985 |